Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents (Q39648836)

13 September 2017

title

Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A105805

25 April 2022

main subject

phase II clinical trial

0 references

1 reference

Wilbanks G Jr

1 reference

13 September 2017

P. D. Bonomi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A105805

25 April 2022

J. Mladineo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A105805

25 April 2022

B. Morrin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A105805

25 April 2022

G. Wilbanks

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A105805

25 April 2022

R. E. Slayton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A105805

25 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=105805

25 April 2022

publication date

1 January 1979

1 reference

13 September 2017

published in

Cancer Treatment Reports

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

137-138

1 reference

13 September 2017

Identifiers

1 reference